• Home
  • Search Results

Search Results

2779 studies match your search

Breast Cancer Study

A Study of Imlunestrant, Investigator s Choice of Endocrine Therapy, and Imlunestrant plus

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targ

To determine if 3-year recurrence-free survival (RFS) is greater than 92% among clinical stages II or IIIa patients with HER2-positive breast cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

NRG-GI008 - Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Have you been diagnosed with colon cancer? If so, you may be able to take part in a research study looking to find out what kind of chemotherapy to recommend to patients based on the presence or absence of circulating tumor DNA (ctDNA) after surgery for colon cancer and if this approach is better or worse than the usual approach for your colon cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Colorectal)
Open

Women's Health Study

We are looking for women between the ages of 18-45 to join a national health study to help us understand the impact of HIV on women's lives and bodies. Both women living with HIV and women without HIV are invited to take part.

Age & Gender
  • 18 years ~ 45 years
  • Female
Study Interest
  • Behavior
  • Healthy Volunteer or General Population
  • Pregnancy
  • and 4 more
Open

Nutrition, Eating, and Mealtimes for Older Adults with Myelodysplastic Syndromes and Acute Myeloid Leukemia, and their Care Partners

Have you been recently diagnosed with Acute Myeloid Leukemia or Myelodysplastic Syndromes? If you are 60 years or older and you are scheduled to receive treatment with hypomethylating agents and Venetoclax, you and your care partner may be able to take part in a research study. In this study, we want to understand nutrition, eating, and mealtimes for people with these cancers. Compensation provided.

Age & Gender
  • 60 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Blood Conditions
  • Cancer (Leukemia)
  • Eating, Nutrition, and Metabolism
Open

A092104: Testing olaparib and temozolomide versus the usual treatment for uterine leiomyosarcoma after chemotherapie

Do you have uterine leiomyosarcoma that has grown after initial treatment with two prior forms of chemotherapy and cannot be removed by surgery? if so you may be able to take part in a research study to find out if the combination of olaparib and temozolomide is better, worse or the same than the usual approach for advanced uterine leiomyosarcoma.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
Not currently enrolling

Extensive Stage Small Cell Lung Cancer Study

The purpose of this study is to learn more about how an investigational drug (tarlatamab) works in people with extensive-stage small cell lung cancer. In this study, we want to learn more about its safety and tolerability (effects good or bad) when used in combination with one of two other drugs (atezolizumab or durvalumab). We also want to learn more about the combination of the study drug with either atezolizumab or durvalumab and carboplatin and etopopside.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung, Phase 1 Trials (all cancers))
Open

Chronic Disease Study

We are looking for people who are between the ages of 30-70 to join a national health study to help us better understand the impact of chronic health conditions on people living with HIV. Both people living with HIV and people without HIV are invited to take part.

Age & Gender
  • 30 years ~ 70 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Healthy Volunteer or General Population
  • LGBTQIA+
  • and 7 more
Open

A Study of Atrasentan in IgA Nephropathy (ASSIST)

Atrasentan is an investigational drug. That means it has not yet been approved by the FDA as a medicine. Researchers want to find out if taking atrasentan along with a drug called an SGLT2 inhibitor is safe and helps people with IgA nephropathy.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
Not currently enrolling

mHealth apps for Smoking Cessation Focus Groups

To determine optimal content and design features of mHealth apps for smoking cessation that are most preferred by Black and African American adults who smoke or use other tobacco products.

Age & Gender
  • 21 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Minority Health
  • Opinions and Perceptions
  • Substance Use (tobacco, alcohol, opioids, etc)
  • Wellness and Lifestyle
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research